| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |